» Articles » PMID: 14569248

PET Myocardial Glucose Metabolism and Perfusion Imaging: Part 1-Guidelines for Data Acquisition and Patient Preparation

Overview
Journal J Nucl Cardiol
Date 2003 Oct 22
PMID 14569248
Citations 26
Authors
Affiliations
Soon will be listed here.
Citing Articles

Myocardial viability assessment during Impella support with 18-fluorodesoxyglucose PET imaging.

Baldetti L, Busnardo E, Pazzanese V, Ricchetti G, Barone G, Sacchi S ESC Heart Fail. 2024; 12(1):683-687.

PMID: 39239887 PMC: 11769665. DOI: 10.1002/ehf2.15053.


Functional and metabolic improvement after coronary intervention for non-viable myocardium detected by F fluorodeoxyglucose positron emission tomography.

Fukushima K, Arashi H, Minami Y, Nakao R, Nagao M, Abe K J Cardiol Cases. 2019; 20(2):57-60.

PMID: 31440313 PMC: 6698253. DOI: 10.1016/j.jccase.2019.03.006.


Cardiac Insulin Resistance in Heart Failure: The Role of Mitochondrial Dynamics.

Saotome M, Ikoma T, Hasan P, Maekawa Y Int J Mol Sci. 2019; 20(14).

PMID: 31330848 PMC: 6678249. DOI: 10.3390/ijms20143552.


Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading.

Sarikaya I, Elgazzar A, Alfeeli M, Sharma P, Sarikaya A J Saudi Heart Assoc. 2018; 30(2):75-85.

PMID: 29910577 PMC: 6000987. DOI: 10.1016/j.jsha.2017.07.001.


Rationale and Design of the CREDENCE Trial: computed TomogRaphic evaluation of atherosclerotic DEtermiNants of myocardial IsChEmia.

Rizvi A, Hartaigh B, Knaapen P, Leipsic J, Shaw L, Andreini D BMC Cardiovasc Disord. 2016; 16(1):190.

PMID: 27716131 PMC: 5053174. DOI: 10.1186/s12872-016-0360-x.